Disease Domain | Count |
---|---|
Infectious Diseases | 17 |
Nervous System Diseases | 1 |
Top 5 Drug Type | Count |
---|---|
Prophylactic vaccine | 14 |
Vaccine | 2 |
Combination vaccine | 2 |
DNA vaccine | 2 |
Inactivated vaccine | 1 |
Top 5 Target | Count |
---|---|
SARS-CoV-2 S protein | 1 |
Target- |
Mechanism Immunostimulants |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. TH |
First Approval Date20 Mar 2019 |
Target- |
Mechanism Immunostimulants |
Active Org. |
Originator Org. |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. TH |
First Approval Date01 Jan 2014 |
Target- |
Mechanism Immunostimulants |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. TH |
First Approval Date01 Jan 2014 |
Start Date19 Jan 2023 |
Sponsor / Collaborator Technovalia, Pty Ltd [+3] |
Start Date14 Dec 2022 |
Sponsor / Collaborator |
Start Date21 Oct 2020 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Hepatitis B vaccine(BioNet-Asia Co. Ltd.) | Hepatitis B More | Approved |
Influenza virus vaccine(BioNet-Asia Co. Ltd.) | Influenza, Human More | Approved |
Typhoid fever vaccine(BioNet-Asia Co. Ltd.) | Typhoid Fever More | Approved |
Recombinant acellular pertussis vaccine(Mahidol University) | Whooping Cough More | Approved |
Pentavalent DTP-Hib-HBV vaccine(BioNet-Asia Co. Ltd.) | Whooping Cough More | Approved |